South Dakota's medical cannabis operators can exhale. Attorney General Marty Jackley concluded this week that the federal government's move to shift marijuana to Schedule III of the Controlled Substances Act will have little practical effect on the state's licensed program. The opinion, issued Tuesday, arrives as state officials nationwide try to figure out what rescheduling actually means for day-to-day operations - and after some South Dakota lawmakers floated repealing the medical cannabis law outright.
Why the Legal Question Mattered
Here's the catch that had legislators worried: if federal law reclassifies marijuana, does that somehow override or conflict with the state's own regulatory structure? Jackley's answer is no. His opinion walks through a preemption analysis - the legal test for whether federal law cancels out state law - and finds none of the three usual triggers apply. Congress hasn't expressly preempted state cannabis programs, it hasn't occupied the entire regulatory field, and South Dakota's medical cannabis statute doesn't conflict with the new federal scheduling. That's a fairly clean bill of health, legally speaking, for dispensaries, cultivators, and testing labs already operating under state license.
Jackley drew a comparison to hemp legalization, where courts recognized that police powers over intrastate commerce remain with the states, and where a no-preemption clause in federal law closed off any argument that Washington had displaced state authority. He sees the same dynamic playing out with Schedule III marijuana.
The DEA Registration Pathway
What actually changes, in practice, is paperwork - not the underlying business model. Under DEA rules tied to the April rescheduling action, state-licensed manufacturers, distributors, and dispensaries can operate in compliance with federal law if they register with the DEA using the agency's new forms for medical marijuana facilities. That's a meaningful distinction for compliance officers and operators: registration isn't automatic, and it isn't optional if a business wants the added layer of federal cover. Multi-state operators with South Dakota footprints should be tracking this closely, since federal registration requirements could eventually intersect with banking relationships, insurance underwriting, and interstate supply arrangements in ways state licensing alone never did.
Jackley was careful to note that rescheduling at the federal level doesn't automatically reschedule marijuana under South Dakota law. The state doesn't currently list marijuana as a controlled substance at all - it simply criminalizes possession and distribution outside the medical program. If lawmakers or voters eventually want to align state scheduling with the federal Schedule III designation, that would require separate legislative or ballot action.
What Operators and Lawmakers Do Next
Lawmakers on the Medical Marijuana Oversight Committee had asked Jackley to assess six potential policy paths forward. His conclusion: none are legally foreclosed by current federal or state law, which effectively punts the decision back to the legislature and voters rather than settling the matter outright.
- Dispensaries and cultivation facilities should confirm their federal DEA registration status alongside existing state licensing to stay ahead of any enforcement ambiguity.
- Compliance teams should watch for legislative action, since repeal bills have already surfaced once this session.
- Operators shouldn't assume federal rescheduling changes state tax treatment, packaging rules, or testing requirements - those remain governed by South Dakota's own regulatory framework.
That last point matters more than it might seem. Federal rescheduling has generated plenty of optimism around 280E tax relief for cannabis businesses nationally, since Schedule III status could open the door to standard business deductions currently denied under the Internal Revenue Code. But state-level compliance - seed-to-sale tracking, lab testing protocols, packaging standards - doesn't shift just because the federal schedule did. South Dakota regulators have already acknowledged they're getting limited federal guidance beyond basic information requests, which means operators should expect a slow, uneven rollout rather than a clean transition. The legal foundation looks stable for now. The operational details are still being written.